Science Daily·3 min read·medium
New weight loss pill beats oral Ozempic in major trial
✦AI Summary
A new oral weight-loss drug, orforglipron, has shown superior efficacy in clinical trials compared to existing injectable options like Ozempic. This development could address patient needle phobia and supply chain issues associated with current GLP-1 medications.
A new type of daily pill has proven more effective for weight loss and blood sugar control than its currently available counterparts, according to a recent trial. The drug, known as orforglipron, could be a game-changer in the rapidly expanding oral weight-loss drug market.
healthsciencebusiness
✦
Get the full story
Sign up for Headlinne to unlock AI insights, political bias analysis, and your personalized news feed.
Create free accountAlready have an account? Sign in